Liver Cancer
Copyright ©The Author(s) 2004.
World J Gastroenterol. Feb 1, 2004; 10(3): 356-360
Published online Feb 1, 2004. doi: 10.3748/wjg.v10.i3.356
Table 1 Clinicopathologic information of patients used in TMA
GroupHBV
Sex
Age
Diameter
Grade
Cirrhosis
TotalPositiveNegativeManFemalemean ± SD (year)mean ± SD (cm)IIIIIIVYesNo
HCC181171101582349.3 ± 10.67.2 ± 3.5281411216615
Normal5052342.4 ± 9.69.3 ± 5.805
Table 2 Expressions of HBx, p65, IκB-α and ubiquitin in HCC and corresponding liver tissues
GroupHBx
p65
IκB-α
Ubiquitin
TotalPositive%TotalPositive%TotalPositive%TotalPositive%
HCC1698147.91707745.317012472.91669859.0
Control17010260.01703520.617111667.0168158.9
Statisticsu = 2.24au = 4.85bu = 1.19u = 9.68b
Table 3 Relativity analysis between HBx, IκB-α, p65 and ubiquitin in HCC and corresponding liver tissues
HBx
P65
Ubiquitin
NegativePositiveNegativePositiveNegativePositive
HBxNegative58(52)30(16)39(57)46(8)
Positive33(83)47(19)28(95)52(7)
Statisticsχ2 = 10.26b(0.60)χ2 = 2.02(1.44)
IκB-αNegative29(21)17(34)36(46)9(9)26(50)17(4)
Positive59(47)63(68)56(89)68(26)42(103)80(11)
Statisticsχ2 = 2.28(0.11)χ2 = 16.86b(1.02)χ2 = 8.90b(0.04)